HERON THERAPEUTICS, INC. /DE/ Public Float
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Public Float of $235.10 million as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $235.10M.
- 2024-06-30: Entity Public Float $394.10M.
- 2023-06-30: Entity Public Float $119.50M.
- 2022-06-30: Entity Public Float $285.40M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $235.10M 10-K · filed 2026-02-26 |
| 2024-06-30 | $394.10M 10-K · filed 2025-02-27 |
| 2023-06-30 | $119.50M 10-K · filed 2024-03-12 |
| 2022-06-30 | $285.40M 10-K · filed 2023-03-29 |
| 2021-06-30 | $1.60B 10-K · filed 2022-02-28 |
| 2020-06-30 | $1.30B 10-K · filed 2021-02-24 |
| 2019-06-28 | $1.40B 10-K · filed 2020-03-02 |
| 2018-06-30 | $2.80B 10-K · filed 2019-02-22 |
| 2017-06-30 | $624.94M 10-K · filed 2018-02-27 |
| 2016-06-30 | $597.12M 10-K · filed 2017-02-23 |
| 2015-06-30 | $957.88M 10-K · filed 2016-02-19 |
| 2014-06-30 | $162.63M 10-K · filed 2015-03-13 |
| 2013-06-30 | $73.73M 10-K · filed 2014-03-07 |
| 2012-06-30 | $76.58M 10-K · filed 2013-03-01 |
| 2011-06-30 | $5.13M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |